| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5105fa3f847b7525a922f233351343de |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 |
| filingDate |
2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c376e7c5474dc445da9e46287008f319 |
| publicationDate |
2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2005281315-A |
| titleOfInvention |
Aqueous pharmacological composition |
| abstract |
PROBLEM TO BE SOLVED: To provide an aqueous composition containing a medicine effective for treating an abnormal physical condition by being present on the surface of a mucous membrane covering a nasal cavity. An aqueous pharmaceutical composition comprising the following ingredients that can be sprayed into the nasal cavity of each individual: (A) solid particles of a pharmacologically effective amount of the drug; and (B) in the composition An amount of a suspending agent effective to maintain a uniform dispersion of the particles and to impart a certain thixotropic property to the composition; and the agent comprises the group consisting of dexamethasone, prednisolone, or triamcinolone acetonide. The above pharmaceutical composition which is a selected anti-inflammatory steroid. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021155124-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018535150-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012533554-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013147480-A |
| priorityDate |
1997-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |